Trials / Completed
CompletedNCT03263520
Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hospital Erasto Gaertner · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare the use of nandrolone associated with corticosteroid for the treatment of cancer-induced malnutrition to treatment with corticosteroids alone in patients with tumors in the high gastro-intestinal tract, liver, pancreas and bile ducts in palliative treatment.
Detailed description
* Compare muscle mass values obtained before and after the use of anabolic steroids upon assessment by bioelectrical impedance analysis (BIA). * Compare the anabolic effect on quality of life (QLo) of the patient before and after the use of anabolic steroids. * Compare data from laboratory tests such as complete blood count, albumin, C reactive protein and transferrin with drug intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nandrolone Decanoate | Drug administration |
| DRUG | Dexamethasone | Drug administration |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-08-30
- Completion
- 2017-10-31
- First posted
- 2017-08-28
- Last updated
- 2019-02-26
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03263520. Inclusion in this directory is not an endorsement.